ANV600 Archives

ANV600

Anaveon announces presentation of ANV600 preclinical data supporting combination therapy with therapeutic PD-1 inhibitors

by admin | Nov 1, 2023 | Press Releases

Anaveon, a clinical stage, immuno-oncology company, today announced that it will present a poster on ANV600 at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) being held from Friday, November 3, 2023, to Sunday, November 5, 2023, in San Diego, California.

Anaveon announces presentation of ANV600 preclinical data supporting combination therapy with therapeutic PD-1 inhibitors

Search here

Categories

Recent Posts

Archives

Anaveon announces presentation of ANV600 preclinical data supporting combination therapy with therapeutic PD-1 inhibitors

Search here

Categories

Recent Posts

We are social

Popular Tags

Archives